lysosomal storage disorder therapy (Chiesi Global Rare Diseases/Aliada Therapeutics)

N/A

Report date: 2025/06/11 11:25:30

Base Information

Drug Namelysosomal storage disorder therapy (Chiesi Global Rare Diseases/Aliada Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionL-type amino acid transporter 1 modulatorsTransferrins modulators
TargetsL-type amino acid transporter 1Transferrins
Therapy Area/IndicationsLysosomal Storage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAliada Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAliada Therapeutics IncChiesi Group
Inactive CompaniesN/A
Active IndicationsLysosomal Storage Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A